Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus

被引:19
|
作者
Ganesh, Sanjeev K. [1 ]
Devi, C. Subathra [1 ]
机构
[1] Vellore Inst Technol, Sch Bio Sci & Technol, Dept Biotechnol, Vellore 632014, Tamil Nadu, India
基金
英国科研创新办公室;
关键词
Autophagy; FKBP-12; Immunosuppressant; Macrolactone; mTOR; Rapamycin; Streptomyces hygroscopicus; HEART-TRANSPLANT RECIPIENTS; BIOSYNTHETIC GENE-CLUSTER; CELL-CYCLE PROGRESSION; STRAND BREAK REPAIR; EXTENDS LIFE-SPAN; MAMMALIAN TARGET; CYCLOSPORINE-A; IMMUNOSUPPRESSANT RAPAMYCIN; MTOR INHIBITORS; PHOSPHATIDYLINOSITOL; 3-KINASE;
D O I
10.1007/s11033-023-08283-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The advancement in pharmaceutical research has led to the discovery and development of new combinatorial life-saving drugs. Rapamycin is a macrolide compound produced from Streptomyces hygroscopicus. Rapamycin and its derivatives are one of the promising sources of drug with broad spectrum applications in the medical field. In recent times, rapamycin has gained significant attention as of its activity against cytokine storm in COVID-19 patients. Rapamycin and its derivatives have more potency when compared to other prevailing drugs. Initially, it has been used exclusively as an anti-fungal drug. Currently rapamycin has been widely used as an immunosuppressant. Rapamycin is a multifaceted drug; it has anti-cancer, anti-viral and anti-aging potentials. Rapamycin has its specific action on mTOR signaling pathway. mTOR has been identified as a key regulator of different pathways. There will be an increased demand for rapamycin, because it has lesser adverse effects when compared to steroids. Currently researchers are focused on the production of effective rapamycin derivatives to combat the growing demand of this wonder drug. The main focus of the current review is to explore the origin, development, molecular mechanistic action, and the current therapeutic aspects of rapamycin. Also, this review article revealed the potential of rapamycin and the progress of rapamycin research. This helps in understanding the exact potency of the drug and could facilitate further studies that could fill in the existing knowledge gaps. The study also gathers significant data pertaining to the gene clusters and biosynthetic pathways involved in the synthesis and production of this multi-faceted drug. In addition, an insight into the mechanism of action of the drug and important derivatives of rapamycin has been expounded. The fillings of the current review, aids in understanding the underlying molecular mechanism, strain improvement, optimization and production of rapamycin derivatives.
引用
收藏
页码:3815 / 3833
页数:19
相关论文
共 15 条
  • [1] Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus
    Sanjeev K. Ganesh
    C. Subathra Devi
    Molecular Biology Reports, 2023, 50 : 3815 - 3833
  • [2] THE CYCLOHEXANE MOIETY OF RAPAMYCIN IS DERIVED FROM SHIKIMIC ACID IN STREPTOMYCES-HYGROSCOPICUS
    PAIVA, NL
    ROBERTS, MF
    DEMAIN, AL
    JOURNAL OF INDUSTRIAL MICROBIOLOGY, 1993, 12 (06): : 423 - 428
  • [3] Production of Rapamycin in Streptomyces hygroscopicus from Glycerol-Based Media Optimized by Systemic Methodology
    Kim, Yong Hyun
    Park, Bu Soo
    Bhatial, Shashi Kant
    Seo, Hyung-Min
    Jeon, Jong-Min
    Kim, Hyun-Joong
    Yi, Da-Hye
    Lee, Ju-Hee
    Choi, Kwon-Young
    Park, Hyung-Yeon
    Kim, Yun-Gon
    Yang, Yung-Hun
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2014, 24 (10) : 1319 - 1326
  • [4] Insights into the metabolic mechanism of rapamycin overproduction in the shikimate-resistant Streptomyces hygroscopicus strain UV-II using comparative metabolomics
    Geng, Huiyan
    Liu, Huanhuan
    Liu, Jiao
    Wang, Cheng
    Wen, Jianping
    WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2017, 33 (06)
  • [5] Leucine aminopeptidase from Streptomyces hygroscopicus is controlled by a low molecular weight inhibitor
    Karadzic, I
    Izrael, L
    Gojgic-Cvjjovic, G
    Vujcic, Z
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2002, 94 (04) : 309 - 314
  • [6] The pipecolate-incorporating enzyme for the biosynthesis of the immunosuppressant rapamycin - Nucleotide sequence analysis, disruption and heterologous expression of rapP from Streptomyces hygroscopicus
    Konig, A
    Schwecke, T
    Molnar, I
    Bohm, GA
    Lowden, PAS
    Staunton, J
    Leadlay, PF
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 247 (02): : 526 - 534
  • [7] Insights into the metabolic mechanism of rapamycin overproduction in the shikimate-resistant Streptomyces hygroscopicus strain UV-II using comparative metabolomics
    Huiyan Geng
    Huanhuan Liu
    Jiao Liu
    Cheng Wang
    Jianping Wen
    World Journal of Microbiology and Biotechnology, 2017, 33
  • [8] A combined approach of classical mutagenesis and rational metabolic engineering improves rapamycin biosynthesis and provides insights into methylmalonyl-CoA precursor supply pathway in Streptomyces hygroscopicus ATCC 29253
    Jung, Won Seok
    Yoo, Young Ji
    Park, Je Won
    Park, Sung Ryeol
    Han, Ah Reum
    Ban, Yeon Hee
    Kim, Eun Ji
    Kim, Eunji
    Yoon, Yeo Joon
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2011, 91 (05) : 1389 - 1397
  • [9] The Multi-Faceted Effect of Curcumin in Glioblastoma from Rescuing Cell Clearance to Autophagy-Independent Effects
    Ryskalin, Larisa
    Biagioni, Francesca
    Busceti, Carla L.
    Lazzeri, Gloria
    Frati, Alessandro
    Fornai, Francesco
    MOLECULES, 2020, 25 (20):
  • [10] A combined approach of classical mutagenesis and rational metabolic engineering improves rapamycin biosynthesis and provides insights into methylmalonyl-CoA precursor supply pathway in Streptomyces hygroscopicus ATCC 29253
    Won Seok Jung
    Young Ji Yoo
    Je Won Park
    Sung Ryeol Park
    Ah Reum Han
    Yeon Hee Ban
    Eun Ji Kim
    Eunji Kim
    Yeo Joon Yoon
    Applied Microbiology and Biotechnology, 2011, 91 : 1389 - 1397